RSS
Pseudomonas aeruginosa (P. aeruginosa)
Visterra awarded R&D contract to advance new candidate
Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). more
Cepheid, MedImmune and Combacte team up against pneumonia
Cepheid is collaborating with Combacte and MedImmune, to identify pneumonia bacteria in patients so they can be entered into clinical programmes more
